The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.50
Bid: 250.00
Ask: 251.00
Change: -1.50 (-0.60%)
Spread: 1.00 (0.40%)
Open: 256.50
High: 256.50
Low: 248.00
Prev. Close: 252.00
GRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update: 2014 home reversion portfolio sale

10 Mar 2015 07:02

RNS Number : 9611G
Grainger PLC
10 March 2015
 



10 March 2015

Update: 2014 home reversion portfolio sale

 

Grainger plc ("Grainger, the "Company" or the "Group"), the UK's largest listed residential property owner and manager, today provides an update on its 2014 home reversions portfolio sale.

 

As was announced on 10 January 2014, Grainger sold Equity Release (Increments) Limited ("ERIL"), which owns a home reversions portfolio, to Clifden Holdings Limited ("Clifden") on terms which included a deferred consideration ("Deferred Consideration") of £35m (being 40% of the total consideration).

 

As announced in Grainger's trading update, issued on 5 February 2015, Clifden had not paid the Deferred Consideration by the final payment date of 9 January 2015, and payment has still not been received as of today's date.

 

Grainger has been in dialogue with Clifden to try to assess its strategy and financial position.

Grainger's security includes the right to the value on optional early termination of certain interest rate caps traded by Clifden. Grainger has now liquidated these caps and the hedge counterparty has contended that the caps have zero value.

Grainger has concluded that, on balance, the most appropriate course of action is to undertake enforcement and exercise its security and rights, which include security over ERIL's share capital.

 

Accordingly, Grainger yesterday appointed two partners from Ernst & Young as administrators of Clifden and agreed to re-acquire the shares of ERIL (subject to FCA consent).

 

It is estimated that the net asset value of ERIL (excluding sums owed to Grainger) is in the region of c. £21m.

 

Work continues to determine the total value recoverable by Grainger, and legal proceedings may be pursued in due course.

 

Grainger will make further announcements with respect to this matter when appropriate.

 

 

For further information, please contact:

 

Grainger plc

FTI Consulting

Andrew Cunningham / Mark Greenwood

Nick On

Telephone (Newcastle): +44 191 261 1819

 

Kurt Mueller

Dido Laurimore / Nick Taylor / Ellie Sweeney

 

Telephone: +44 (0) 20 3727 1000

Telephone (London): +44 (0) 20 7940 9500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFEDVEIAIIE
Date   Source Headline
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20224:00 pmRNSResult of AGM
9th Feb 20227:00 amRNSTrading Update
8th Feb 202210:10 amRNSDirector/PDMR Shareholding
4th Feb 202212:26 pmRNSTotal Voting Rights
4th Feb 202212:26 pmRNSDirector/PDMR Shareholding
26th Jan 202211:47 amRNSHolding(s) in Company
11th Jan 20221:13 pmRNSAGM Statement
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
20th Dec 202110:26 amRNSDirector/PDMR Shareholding
20th Dec 202110:20 amRNSDirector/PDMR Shareholding
6th Dec 202111:31 amRNSDirector/PDMR Shareholding
24th Nov 202110:03 amRNSEBT purchase
23rd Nov 20217:00 amRNSGrainger Trust Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.